glp 1 agonists canada GLP-1 Market Report 2025-2033, By Product, Molecule, and Geo The expanding role of GLP-1
Description
The indications for the use of GLP1-RA in the study included weight loss (n=117, 70%), diabetes (n=46, 28%) and other indications (n=4, 2%) such as PCOS, dumping syndrome or metabolic syndrome (online supplemental figure 1)

Tirzepatide (weekly dual GIP + GLP-1 agonist

Therefore, both agonists and antagonists of the GIP receptor may be useful for the therapy of obesity (46)

Tang ST, Tang HQ, Su H, Wang Y, Zhou Q, Zhang Q, Wang Y, Zhu HQ

This insulotropic activity lowers blood glucose levels, reducing the peak of post-prandial hyperglycaemia

As with glucagon, the structural similarity of GLP-1 and GIP provided the opportunity for rationally engineering single molecules of chimeric design [937]
